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Summary. This review focuses on the current 
knowledge about the function of the EGF-like homeotic 
protein dlk. dlk is a transmembrane protein that 
possesses six Epidermal Growth Factor-like sequences at 
the extracellular domain, a single transmembrane 
domain and a short intracellular tail. Because of its 
overall structure and amino acid homology, dlk belongs 
to the EGF-like homeotic protein family. This family 
includes proteins such as the Notch receptor and its 
homologues, as well as Notch ligands, such as Delta, 
Serrate, and their mammalian homologues DIl1, D112 
and D113 and Jagged 1 and Jagged 2. (For a recent 
review see Fleming, 1998). dlk is highly expressed by 
preadipose cell lines, and neuroendocrine tumors, such 
as pheochromocytomas and neuroblastomas. dlk has 
been involved in several differentiation processes, such 
as adipogenesis, hematopoiesis and B cell lympho- 
poiesis, and neuroendocrine differentiation, including the 
differentiation of pancreas and the adrenal gland. The 
extracellular region of dlk can be released by action of 
an unknown protease and this soluble dlk variant 
accumulates in the amniotic fluid and is able to inhibit 
adipocyte differentiation in vitro. Recent evidence 
indicates, however, that membrane-associated dlk 
variants play a positive role in the differentiation 
process. These findings suggest that dlk plays an 
important role in differentiation and tumorigenesis of 
several cellular types. 
Key words: EGF-like, Homeotic genes, Adipogenesis, 
Neuroendocrine, Differentiation 
Introduction 
It is sometimes said that some scientific discoveries 
are made only when the scientific community is ready 
for them. This might well be the case for dlk. At least, as 
we will see, its discovery reflects the popularization of 
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certain molecular biology techniques. dlk has been 
discovered or rediscovered not less than six independent 
times. For that reason, dlk has received many names: 
pG2 (Helman et al., 1987), FA-1 (Fay et al., 1988), Pref- 
1 (Smas and Sul, 1993), SCP-l (Maruyama et al, 1993), 
ZOG (Halder et al., 1998), dlk (Laborda et al., 1993). 
Throughout the article, the name dlk will be used mainly 
for the reason that Dlkl has been accepted as the official 
name for this gene. 'The many different names used for 
this gene have created considerable confusion in the 
literature. In addition, because dlk has been discovered 
or rediscovered in association with diverse biological 
systems, confusion has also resulted due to each research 
group, including ours, understandably focussing on the 
relevance of this gene for the particular biological 
system under study. This has inadvertently resulted in 
minimizing the implications of the findings realized 
by other groups in different biological systems. 
Consequently, a newcomer to the field would have some 
difficulty to gather all the literature pertaining to this 
subject, and arrive to understand the current knowledge 
about the function of this gene. This review is intended 
to summarize the current knowledge about the function 
of dlk in the diverse biological systems in which it has 
been implicated, and to clarify the nomenclature 
confusion existing in the literature. 
The discovery of dlk 
The first confirmed record of the discovery of dlk is 
more than a decade old. Prior to that date, it is possible 
that dlk could have been detected as an unknown serum 
or  placental protein or tumor antigen. In a paper 
published in 1987 Helman et al. used differential 
hybridization techniques to identify genes highly 
expressed in the adrenal medullar neuroendocrine tumor, 
pheochromocytoma, but absent from the more immature 
tumor of the adrenal medulla, neuroblastoma. One of 
these genes was named pG2. As we will se later, this 
gene resulted to be dlk. According to the data presented 
by this group, pG2 was highly expressed in adrenal 
cortex but also in the adrenal medulla, though to be 
embryologically unrelated to the cortex. These authors 
proposed that pG2 was organ-specific, rather that tissue 










